Chylopericardium in a Dog with Concurrent Chylothorax, Mesothelioma, and Bilateral Brachiocephalic Vein Thrombosis: A Case Report Authors: Tomohiro Yoshida, Kazuyuki Terai, Aki Takeuchi, Akari Hatanaka, Rio Hayashi, Yusuke Takahashi, Daisuke Ito, Hussein M. El-Husseiny, Takashi Tanaka, Ryou Tanaka Published: 2026 ABSTRACT Simple SummaryChylopericardium is a very rare condition in dogs in which a milky fluid called chyle accumulates around the heart. This fluid buildup can interfere with normal heart function and cause breathing difficulty and reduced activity. Because the condition is uncommon, its causes and best treatments are not well understood. In this report, we describe a dog with chylopericardium that also had chyle accumulation in the chest, blood clots in large veins near the heart, and a type of cancer called mesothelioma. These problems appeared to influence each other, making diagnosis and treatment difficult. The dog was treated using a combination of surgery to reduce lymphatic fluid pressure, medication to prevent blood clots, and chemotherapy delivered directly into the chest. Despite the presence of several serious and interacting diseases, the abnormal fluid around the heart and lungs was successfully controlled over a long period. This case shows that using multiple treatments together and carefully evaluating underlying causes can lead to good outcomes, even in complex and rare conditions. The findings may help veterinarians better understand and manage similar cases in the future. 1. Introduction Chylopericardium is an extremely rare disorder characterized by the accumulation of chyle within the pericardial cavity [1,2,3,4,5,6,7]. In dogs, only a limited number of clinical cases have been reported, and the pathogenesis and optimal treatment strategies remain poorly understood [1,3,4,6,8,9]. The pathogenesis of chylopericardium is generally divided into two categories: primary and secondary [2,5,7,10]. Primary chylopericardium is presumed to result from abnormal communications between the thoracic duct and the pericardial lymphatic system [2,3,5,6,7,9]. In contrast, secondary chylopericardium is associated with increased thoracic duct or central venous pressure, leading to retrograde lymphatic flow into the pericardial cavity [1,2,3,5,6,7,11]. Reported secondary causes in dogs include right-sided heart failure, intrathoracic neoplasia, venous thrombosis, and cardiac tumors; however, in many cases, the precise etiology cannot be definitively identified [1,4,6,8]. Clinically, chylopericardium is associated with signs related to cardiac tamponade, including respiratory distress and exercise intolerance [2,7]. Diagnosis is typically achieved by pericardiocentesis followed by fluid analysis, with confirmation based on a triglyceride concentration higher than that of serum [7,12]. Although repeated drainage may provide temporary symptomatic relief, definitive management generally requires surgical intervention [5,7,9]. Here, we report an extremely rare case of chylopericardium in a dog concurrently affected by chylothorax, bilateral brachiocephalic vein thrombosis, and mesothelioma. This case is notable not only for the unusual combination of multiple interacting disease processes, but also for the successful long-term management achieved through a comprehensive treatment strategy that included thoracic duct ligation, subtotal pericardiectomy, cisterna chyli ablation, antithrombotic therapy, and intrathoracic chemotherapy. The present report aims to describe the diagnostic considerations, therapeutic decision-making process, and potential pathophysiological interactions among these conditions, thereby contributing additional clinical observations to the existing literature on complex canine chylopericardium. 2. Case Description A 6-year-old, 12.06-kg, neutered male Shiba Inu was referred to our medical facility with respiratory distress. Thoracic radiography performed at the referring veterinary clinic revealed pleural effusion. Thoracocentesis yielded 1.2 L of milky white fluid, and biochemical analysis demonstrated a pleural fluid triglyceride concentration >500 mg/dL, exceeding the serum triglyceride concentration of 148 mg/dL. Based on these findings, chylothorax was diagnosed. Although medical management was initiated, no clinical improvement was observed, and the dog was presented to our institution for further diagnostic evaluation and treatment. According to the medical history, the dog exhibited decreased activity, and appetite had declined to approximately 50% of normal. Physical examination revealed a body temperature of 38.0 °C, a heart rate of 180 beats/min, a respiratory rate of 72 breaths/min, and a body condition score of 6/9. At initial presentation, complete blood count (IDEXX ProCyte Dx; IDEXX Laboratories, Inc., Westbrook, ME, USA) and serum biochemical analysis (DRI-CHEM NX700; FUJIFILM Corporation, Tokyo, Japan) were performed. Laboratory findings and corresponding reference intervals are presented in Table 1. Thoracic radiography showed increased pulmonary opacity obscuring cardiac silhouettes and visible interlobar fissures, consistent with pleural effusion. Thoracic ultrasonography confirmed the presence of pleural effusion and pericardial effusion (Figure 1). The pericardial effusion resulted in compression of the right atrium; however, no other structural cardiac abnormalities were identified. Under ultrasound guidance, 500 mL of pleural fluid and 45 mL of pericardial fluid were aspirated. Both fluids were turbid and milky white in appearance. Cytological examination revealed predominantly small lymphocytes, mesothelial cells, and macrophages, with no evidence of infection. Biochemical analysis of the pericardial fluid showed triglyceride concentrations >500 mg/dL and a total cholesterol of 70 mg/dL, consistent with a diagnosis of chylopericardium. To further investigate the underlying causes of chylothorax and chylopericardium, whole-body computed tomography (CT) was performed sequentially with non-contrast, lymphangiographic, and angiographic phases. For CT lymphangiography, the contrast medium (Iopamiron; Bayer Yakuhin, Ltd., Osaka, Japan) was injected into both plantar pads at a dose of 0.5 ml/kg each, followed by a massage for 3 min. CT lymphangiography revealed three thoracic ducts at the level of the diaphragm (Figure 2A). No obvious contrast leakage site or clear communication between the thoracic duct and pericardial lymphatics was identified (Figure 2E). CT angiography revealed bilateral brachiocephalic vein thrombosis and enlargement of the tracheobronchial and mediastinal lymph nodes (Figure 2B–D). Because medical management at the referring clinic was ineffective, surgical intervention was planned and performed on day 5 after admission. The planned procedures included subtotal pericardiectomy, thoracic duct ligation, cisterna chyli ablation, and mediastinal tissue biopsy. A small amount of butter was administered orally preoperatively to enhance intraoperative visualization of lymphatic vessels. Premedication included atropine sulfate (0.05 mg/kg SC; Atropine Sulfate Injection 0.5 mg; Mitsubishi Tanabe Pharma Co., Osaka, Japan), fentanyl (5 mcg/kg IV; Fentanyl Injection 0.25 mg; Daiichi Sankyo Propharma Co., Ltd., Tokyo, Japan) and midazolam hydrochloride (0.2 mg/kg IV; Dormicum injection 10 mg; Maruishi Pharmaceutical Co., Ltd., Osaka, Japan). Perioperative antimicrobial prophylaxis consisted of cefazolin sodium (20 mg/kg IV; Nichi-Iko Pharmaceutical, Toyama, Japan). Anesthesia was induced with intravenous propofol (3 mg/kg; Fresenius Kabi, Tokyo, Japan). After endotracheal intubation, anesthesia was maintained with isoflurane (MSD Animal Health, Rahway, NJ, USA) delivered in oxygen. Fentanyl was administered as a continuous rate infusion during surgery. The dog was positioned in left lateral recumbency, and a right 7th-intercostal thoracotomy was performed. Upon entering the thoracic cavity, chylous pleural effusion was observed. Partial incision of the pericardium revealed milky white fluid within the pericardial cavity, which was collected for analysis (Figure 3A,B). Subsequently, diffuse thickening of the pericardium and mediastinal tissues was observed intraoperatively. Although CT angiography had demonstrated enlargement of the tracheobronchial and mediastinal lymph nodes, these lymph nodes could not be clearly distinguished because of the diffuse thickening of the surrounding mediastinal tissues. Therefore, the diffusely thickened pericardial and mediastinal tissues were resected using a sealing device for histopathological examination (Figure 3C). To facilitate identification of the thoracic duct, indocyanine green (Diagnogreen for Injection 25 mg; Daiichi Sankyo Co., Ltd., Tokyo, Japan) was injected into both plantar pads (5 mL per pad). Three thoracic ducts were identified near the diaphragm and ligated together as caudally as possible using a large size double-shanked vascular surgical clip (DS Titanium Ligation Clips; B. BRAUN Aesculap, Tokyo, Japan) and non-absorbable suture. After placement of a thoracic drain, the thoracotomy incision was closed routinely. The dog was subsequently repositioned in dorsal recumbency for a ventral midline celiotomy. The cisterna chyli located around the abdominal aorta was disrupted, and leakage of lymphatic fluid was confirmed. The abdomen was subsequently closed routinely. Biochemical analysis of the pericardial fluid revealed glucose 122 mg/dL, total cholesterol 94 mg/dL, total protein 3.5 g/dL, albumin 1.4 g/dL, and triglycerides > 500 mg/dL, confirming chylous effusion. Postoperative recovery was uneventful. By postoperative day 2, pleural fluid production had decreased to approximately 10 mL, and the dog was discharged with the thoracic drain in place. Oral clopidogrel sulfate (Plavix® Tablets 25 mg; Sanofi K.K., Tokyo, Japan, 2.2 mg/kg) was initiated for brachiocephalic vein thrombosis. On day 12, 350 mL of pale reddish pleural fluid was aspirated. Biochemical analysis showed a triglyceride concentration of 75 mg/dL, lower than the serum value, indicating that the effusion was not chylous. Similar findings were observed on day 20, 750 mL of similar effusion was drained, and triglyceride concentration remained lower than serum concentrations. On day 27, 700 mL of pleural fluid was aspirated. The pleural fluid triglyceride concentration was 182 mg/dL, while serum triglyceride concentration was 121 mg/dL, raising suspicion of chylous effusion recurrence. Histopathological examination of the resected pericardial and mediastinal tissues revealed diffuse proliferation of atypical mesothelial cells, consistent with mesothelioma (Figure 4A,B). These findings were considered most consistent with mesothelioma. Based on these findings, reaccumulation of chylous effusion was considered likely to be associated with mesothelioma, and chemotherapy was initiated. Carboplatin (Carboplatin Injection 150 mg; Nichi-Iko Pharmaceutical Co., Ltd., Toyama City, Japan, 100 mg/m2) was diluted and administered intrathoracically via the chest tube. The treatment protocol was based on a previously reported intrathoracic carboplatin regimen for canine mesothelioma [13]. The dog was repositioned to ensure uniform distribution of the drug within the thoracic cavity. On day 41, no pleural effusion was detected, and carboplatin (100 mg/m2) was administered via the chest tube again. On day 46, the dog was presented following spontaneous removal of the chest tube; no pleural effusion or pneumothorax was observed (Figure 5). After discussion with the owner, chemotherapy was discontinued, and clopidogrel therapy was continued. Temporal changes in pleural fluid triglyceride concentration during treatment. Pleural fluid triglyceride (TG) concentration remained >500 mg/dL before surgery, consistent with chylous effusion. Following subtotal pericardiectomy, thoracic duct ligation, and cisterna chyli ablation (Day 5), the pleural fluid TG concentration decreased to 75 mg/dL on Day 12, which was lower than the serum TG concentration and therefore not consistent with chylous effusion. On Day 27, pleural fluid TG increased to 182 mg/dL, exceeding the serum TG concentration (121 mg/dL), suggesting recurrence of chylous effusion. Intrathoracic carboplatin (100 mg/m2) was administered on Days 27 and 41, after which no pleural effusion was detected. Values exceeding 500 mg/dL are indicated as >500 mg/dL. Four months after initiation of clopidogrel therapy, CT angiography performed as part of the preoperative evaluation for an unrelated disease confirmed complete resolution of the bilateral brachiocephalic vein thrombosis. Clopidogrel was discontinued at that time. No clinically apparent bleeding complications were observed during the treatment period. Subsequent follow-up examinations revealed no recurrence of pleural effusion. The dog ultimately died on day 267 due to the rupture of a hepatic hemangiosarcoma, with no evidence of pleural effusion recurrence observed until death. 3. Discussion Chylopericardium is an extremely rare disease in dogs, and its pathophysiology remains incompletely understood [9]. In the present case, diagnostic imaging revealed three abnormalities—chylopericardium, chylothorax, and bilateral brachiocephalic vein thrombosis—all of which are associated with disturbances in lymphatic or venous flow. However, no definitive findings suggestive of a neoplastic lesion were identified. Accordingly, the initial diagnostic reasoning and treatment strategy focused primarily on abnormalities of lymphatic and venous circulation. Brachiocephalic vein thrombosis can increase central venous pressure and thoracic duct pressure, thereby contributing to the development of both chylothorax and chylopericardium [1,8,14]. Conversely, chylopericardium may result in cardiac tamponade, leading to impaired venous return and venous congestion, which in turn increases the risk of thrombosis [15]. In addition, elevations in venous and thoracic duct pressures can promote the development of chylothorax [9,14]. Chylothorax is known to occur idiopathically in dogs, particularly in predisposed breeds [16]. Chronic chylothorax can induce pericardial inflammation and fibrosis, resulting in pericardial thickening [9]. In the present case, in addition to mesothelioma-associated pathology, chylothorax-associated pericardial thickening may have caused impaired diastolic cardiac filling and venous return, thereby contributing to the development or progression of chylopericardium and brachiocephalic vein thrombosis [9,14]. Collectively, these findings suggest that chylopericardium, chylothorax, and brachiocephalic vein thrombosis in this case were not isolated causes or consequences, but rather were interconnected through a self-amplifying, cyclical pathophysiological mechanism involving abnormal lymphatic and venous pressure dynamics. Based on the clinical findings and histopathological diagnosis, we consider this case most consistent with secondary chylopericardium resulting from a multifactorial mechanism involving bilateral brachiocephalic vein thrombosis and mesothelioma-associated lymphatic dysfunction. Given the absence of a clearly identifiable primary disorder and the presence of multiple interrelated processes acting in a self-perpetuating cycle, an underlying neoplastic condition—particularly mesothelioma—was considered as a possible contributing factor. Accordingly, mediastinal tissue biopsy was performed for diagnostic purposes, and pericardiectomy was undertaken for both diagnostic and therapeutic purposes [13]. Mesothelioma has been reported as a potential cause of chylothorax in human medicine, although such cases are exceedingly rare [17,18]. To the authors’ knowledge, however, there have been no reports in either human or veterinary medicine describing mesothelioma as a direct cause of chylopericardium. Mesothelioma often does not form discrete mass lesions and can therefore be difficult to visualize using standard imaging modalities [3]. For this reason, in the present case, macroscopically thickened pericardial and mediastinal tissues identified intraoperatively were resected and submitted for histopathological examination demonstrated findings most consistent with mesothelioma in both the pericardial and mediastinal tissues [19]. Although a direct causal relationship between mesothelioma and chylopericardium cannot be conclusively established, several mechanisms may be implicated, including increased thoracic duct pressure secondary to tumor embolization within lymphatic vessels, or direct compression or disruption of the thoracic duct by neoplastic infiltration [3,17,18]. These processes could lead to retrograde lymphatic flow or chyle leakage, thereby contributing to the development of chylopericardium. Furthermore, neoplasia is recognized as a risk factor for thrombosis in dogs through cancer-associated hypercoagulability. Therefore, in the present case, mesothelioma may have contributed not only to lymphatic obstruction but also to the development of bilateral brachiocephalic vein thrombosis through cancer-associated hypercoagulability. Together, these mechanisms may have acted synergistically to promote the development of chylopericardium. However, because coagulation testing was not performed, this proposed mechanism could not be confirmed in the present case. Transient non-chylous pleural effusion was observed shortly after surgery, which may have represented postoperative inflammatory or serosanguinous effusion rather than persistent chylous leakage. However, recurrence of chylous effusion following surgery, together with its subsequent resolution after intrathoracic carboplatin administration and the histopathological diagnosis of mesothelioma, suggests that the underlying neoplastic process may have contributed to persistent impairment of lymphatic drainage, although direct evidence of lymphatic invasion was not identified. The intrathoracic carboplatin regimen was selected with reference to a previously reported protocol for canine mesothelioma [13]. Because the optimal intrathoracic dose has not yet been established in dogs, a lower dose (100 mg/m2) than that previously reported was selected to reduce the risk of adverse effects. As the first administration was well tolerated and effectively controlled pleural effusion, the same dose was used for the second treatment. No clinically apparent local or systemic adverse effects were observed following either administration. Standardized surgical treatment strategies for chylopericardium in dogs have not been established. Because evidence regarding surgical treatment of canine chylopericardium is limited, the surgical strategy was based primarily on recommendations from the human medical literature, where thoracic duct ligation combined with partial pericardiectomy is generally recommended [5,9]. In addition, because chylothorax was concurrently present, cisterna chyli ablation was performed as an adjunctive surgical procedure [14,16]. In human medicine, CT lymphangiography is considered a useful technique for evaluating lymphatic anatomy and identifying sites of lymphatic leakage or obstruction [2,5,6,7,9,10]. In the present case, CT lymphangiography, together with preoperative oral butter administration and intraoperative intralymphatic injection of indocyanine green, was used to facilitate visualization of the lymphatic system. However, neither the pericardial lymphatic network nor the site of chyle leakage could be definitively identified [8,20,21]. Similarly, previous reports have indicated that precise localization of lymphatic leakage is rarely achievable either preoperatively or intraoperatively, suggesting that accurate identification of leakage sites remains challenging [9]. Although precise identification of the chyle leakage site remains an important goal for future investigations, a surgical strategy focusing on interruption and decompression of lymphatic flow at multiple levels was considered to be a rational approach under the current clinical circumstances. Furthermore, antithrombotic therapy was instituted for bilateral brachiocephalic vein thrombosis, and intrathoracic carboplatin chemotherapy was administered following the diagnosis of mesothelioma. Although surgical intervention achieved immediate decompression of the lymphatic system and temporary control of chylous effusion, long-term control of chylous effusion appeared to be associated with subsequent oncologic response. No recurrence of chylous effusion was observed until the dog died from an unrelated hepatic hemangiosarcoma. Although encouraging, this favorable outcome was observed in a single case, and further studies are needed to determine whether a similar approach is beneficial in other dogs. This report has several limitations. First, although the clinicopathological findings were considered most consistent with mesothelioma, immunohistochemical examination was not performed, and reactive mesothelial hyperplasia could not be completely excluded. Second, coagulation testing, including antithrombin activity and D-dimer concentration, was not performed; therefore, the contribution of cancer-associated hypercoagulability to the development of bilateral brachiocephalic vein thrombosis could not be fully evaluated. Third, although the clinical findings support a pathophysiological association among mesothelioma, chylothorax, bilateral brachiocephalic vein thrombosis, and chylopericardium, causality could not be definitively established. Finally, as this is a single case report, these findings should be interpreted with caution and cannot be generalized to other dogs. Additional studies and accumulation of similar cases are required to further clarify these pathophysiological relationships. 4. Conclusions This report describes an exceptionally rare case of canine chylopericardium associated with chylothorax, bilateral brachiocephalic vein thrombosis, and mesothelioma. Although a direct causal relationship between mesothelioma and chylopericardium could not be established, the clinical course suggests that mesothelioma may have contributed to the development of chylopericardium through impairment of lymphatic drainage. A combined treatment strategy consisting of surgical lymphatic decompression, antithrombotic therapy, and intrathoracic chemotherapy achieved long-term control of chylous effusion in this individual case. This case highlights the importance of considering occult neoplasia in dogs with complex chylopericardium. Additional case reports and larger studies are needed to determine whether similar outcomes can be achieved in other dogs.